Bluesky Facebook Reddit Email

Presence of SARS-CoV-2 RNA in cornea of patients with COVID-19

01.21.21 | JAMA Network

CalDigit TS4 Thunderbolt 4 Dock

CalDigit TS4 Thunderbolt 4 Dock simplifies serious desks with 18 ports for high-speed storage, monitors, and instruments across Mac and PC setups.

What The Study Did: Evidence of SARS-CoV-2 RNA in human corneas was examined in this study.

Authors: Maria Casagrande, M.D., of the University Medical Center Hamburg-Eppendorf in Hamburg, Germany, is the corresponding author.

To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/

(doi:10.1001/jamaophthalmol.2020.6339)

Editor's Note: The article includes conflict of interest and funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

###

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaophthalmology/fullarticle/10.1001/jamaophthalmol.2020.6339?guestAccessKey=1c1f798b-2b75-4893-ba0a-1dfb22237efd&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=012121

JAMA Ophthalmology

Keywords

Article Information

Contact Information

JAMA Network Media Relations
mediarelations@jamanetwork.org

How to Cite This Article

APA:
JAMA Network. (2021, January 21). Presence of SARS-CoV-2 RNA in cornea of patients with COVID-19. Brightsurf News. https://www.brightsurf.com/news/1470RVG1/presence-of-sars-cov-2-rna-in-cornea-of-patients-with-covid-19.html
MLA:
"Presence of SARS-CoV-2 RNA in cornea of patients with COVID-19." Brightsurf News, Jan. 21 2021, https://www.brightsurf.com/news/1470RVG1/presence-of-sars-cov-2-rna-in-cornea-of-patients-with-covid-19.html.